HR 7384
Creating Hope Reauthorization Act of 2024
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The Creating Hope Reauthorization Act of 2024 extends a program within the Food and Drug Administration that provides priority review vouchers to companies developing treatments for rare diseases affecting children. These vouchers allow manufacturers to expedite the FDA review process for their drugs. The bill aims to encourage the development of medications for these often-overlooked conditions by reducing the time and cost associated with drug approval. This extension will continue the program through September 30, 2028, with adjustments to the voucher validity dates.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Abigail Davis Spanberger
Anna G. Eshoo
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.